Patents by Inventor Stephen T.C. Wong

Stephen T.C. Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230363679
    Abstract: A system includes a mobile device for capturing raw video of a subject, a preprocessing system communicatively coupled to the mobile device for splitting the raw video into an image stream and an audio stream, an image processing system communicatively coupled to the preprocessing system for processing the image stream into a spatiotemporal facial frame sequence proposal, an audio processing system for processing the audio stream into a preprocessed audio component, one or more machine learning devices that analyze the facial frame sequence proposal and the preprocessed audio component according to a trained model to determine whether the subject is exhibiting signs of a neurological condition, and a user device for receiving data corresponding to a confirmed indication of neurological condition from the one or more machine learning devices and providing the confirmed indication of neurological condition to the subject and/or a clinician via a user interface.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 16, 2023
    Applicants: THE PENN STATE RESEARCH FOUNDATION, THE METHODIST HOSPITAL
    Inventors: James Z. Wang, Mingli Yu, Tongan Cai, Xiaolei Huang, Kelvin Wong, John Volpi, Stephen T.C. Wong
  • Publication number: 20220168322
    Abstract: In one aspect, the present disclosure provides methods of inhibiting STAT3 in a cell comprising contacting the cell with a compound of the formula: (I) wherein the variables are as defined herein. In another aspect, the present disclosure provides methods of using of the compounds disclosed herein for the treatment of cancer.
    Type: Application
    Filed: July 19, 2019
    Publication date: June 2, 2022
    Applicants: Board of Regents, The University of Texas System, The Methodist Hospital dba Houston Methodist Hospital
    Inventors: David John TWEARDY, Ren KONG, Uddalak BHARADWAJ, Moses Makokha KASEMBELI, Stephen T. C. WONG
  • Patent number: 10913068
    Abstract: A testing device is provided. The testing device includes a capturing tool and a microfluidic chip having a plurality of chambers connected in a network, a sample receiving port connected to the network, and a guide structure configured to receive the capturing tool, wherein the capturing tool is configured to capture sample in a distal position from the guide structure and further configured to transfer the captured sample to the sample receiving port in a proximal position from the guide structure.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: February 9, 2021
    Assignees: Nanyang Technological University, Agency For Science, Technology and Research, The Methodist Hospital
    Inventors: Joseph Sylvester Chang, Geok Soon Lim, Lei Zhang, Zhiping Wang, Ruige Wu, Stephen T. C. Wong, Kemi Cui
  • Patent number: 10765675
    Abstract: A method for treating a sarcoma by administering a tyrosine kinase inhibitor and a biguanide compound. Also described is a method for treating a tumor of the Ewing Sarcoma family by obtaining a tumor sample; determining in the sample gene expression levels of ACTB, B2M, MLH1, PRKDC, XPC, APEX1, ERCC5, MMS19, or RAD23; and administering a tyrosine kinase inhibitor and a biguanide compound. Furthermore, a pharmaceutical composition for treating a Ewing family tumor is disclosed. The composition contains a tyrosine kinase inhibitor, a biguanide compound, and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: September 8, 2020
    Assignee: The Methodist Hospital
    Inventors: Hong Zhao, Stephen T. C. Wong
  • Publication number: 20200121666
    Abstract: The present disclosure relates to compounds that are useful as tau phosphorylation inhibitors. Further disclosed are compounds and methods for treating or preventing Alzheimer's disease.
    Type: Application
    Filed: June 5, 2018
    Publication date: April 23, 2020
    Inventors: Stephen T.C. WONG, Xiaofeng XIA, Xiaoyun XU, Doo Yeon KIM, Rudolph E. TANZI
  • Patent number: 10314811
    Abstract: A method for treating diarrhea induced by a chemotherapy agent by administering a carboxylesterase 2 (CES2) inhibitor, i.e., hesperetin, naringenin, or 2?,4?-dihydroxychalcone. Also disclosed is a method for treating cancer by administering a chemotherapy agent together with hesperetin, naringenin, or 2?,4?-dihydroxychalcone. Furthermore, a composition for treating cancer is provided, the composition containing a chemotherapy agent and hesperetin, naringenin, or 2?,4?-dihydroxychalcone.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: June 11, 2019
    Assignee: The Methodist Hospital
    Inventors: Ren Kong, Hong Zhao, Stephen T. C. Wong
  • Publication number: 20190010533
    Abstract: The present disclosure relates to methods for screening for a modulator of a target protein. The present disclosure further relates to a systematic disease drug repositioning (SMART) method which integrates experimental and computational biology methods systematically with public transcriptomic profile data to enable fast-track identification and confirmation of novel drug candidates.
    Type: Application
    Filed: June 5, 2018
    Publication date: January 10, 2019
    Inventor: Stephen T.C. Wong
  • Publication number: 20180243299
    Abstract: A method for treating a sarcoma by administering a tyrosine kinase inhibitor and a biguanide compound. Also described is a method for treating a tumor of the Ewing Sarcoma family by obtaining a tumor sample; determining in the sample gene expression levels of ACTB, B2M, MLH1, PRKDC, XPC, APEX1, ERCC5, MMS19, or RAD23; and administering a tyrosine kinase inhibitor and a biguanide compound. Furthermore, a pharmaceutical composition for treating a Ewing family tumor is disclosed. The composition contains a tyrosine kinase inhibitor, a biguanide compound, and a pharmaceutically acceptable excipient.
    Type: Application
    Filed: August 22, 2016
    Publication date: August 30, 2018
    Inventors: Hong Zhao, Stephen T.C. Wong
  • Publication number: 20180235928
    Abstract: A method for treating diarrhea induced by a chemotherapy agent by administering a carboxylesterase 2 (CES2) inhibitor, i.e., hesperetin, naringenin, or 2?,4?-dihydroxychalcone. Also disclosed is a method for treating cancer by administering a chemotherapy agent together with hesperetin, naringenin, or 2?,4?-dihydroxychalcone. Furthermore, a composition for treating cancer is provided, the composition containing a chemotherapy agent and hesperetin, naringenin, or 2?,4?-dihydroxychalcone.
    Type: Application
    Filed: August 18, 2016
    Publication date: August 23, 2018
    Inventors: Ren Kong, Hong Zhao, Stephen T.C. Wong
  • Publication number: 20180214878
    Abstract: A testing device is provided. The testing device includes a capturing tool and a microfluidic chip having a plurality of chambers connected in a network, a sample receiving port connected to the network, and a guide structure configured to receive the capturing tool, wherein the capturing tool is configured to capture sample in a distal position from the guide structure and further configured to transfer the captured sample to the sample receiving port in a proximal position from the guide structure.
    Type: Application
    Filed: March 14, 2016
    Publication date: August 2, 2018
    Inventors: Joseph Sylvester CHANG, Geok Soon LIM, Lei ZHANG, Zhiping WANG, Ruige WU, Stephen T.C. WONG, Kemi CUI
  • Patent number: 9651554
    Abstract: Disclosed are molecular diagnostic compositions and methods for predicting brain metastasis of breast cancer, as well as methods for drug repositioning to identify existing and new therapeutics for use in developing individualized, patient-specific treatment regimens for improving diagnoses and patient outcomes in individuals at risk for brain metastasis of breast cancer.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: May 16, 2017
    Assignee: The Methodist Hospital Research Institute
    Inventors: Stephen T. C. Wong, Hong Zhao
  • Publication number: 20120184560
    Abstract: Disclosed are molecular diagnostic compositions and methods for predicting brain metastasis of breast cancer, as well as methods for drug repositioning to identify existing and new therapeutics for use in developing individualized, patient-specific treatment regimens for improving diagnoses and patient outcomes in individuals at risk for brain metastasis of breast cancer.
    Type: Application
    Filed: September 26, 2011
    Publication date: July 19, 2012
    Applicant: The Methodist Hospital Research Institute
    Inventors: Stephen T.C. Wong, Hong Zhao
  • Publication number: 20120022367
    Abstract: An endoscopic microscopic system for collecting and processing a sequence of images in order to provide diagnosis and treatment.
    Type: Application
    Filed: July 14, 2011
    Publication date: January 26, 2012
    Inventors: Stephen T.C. Wong, Zhiyong Wang, Ganesh Palpattu, Liang Gao
  • Publication number: 20120010513
    Abstract: An endoscopic microscopic system for collecting and processing a sequence of images.
    Type: Application
    Filed: January 25, 2011
    Publication date: January 12, 2012
    Inventors: Stephen T.C. Wong, Zhiyong Wang, Ganesh Palapattu, Liang Gao